Skip to main content

Closed

NCNA: NuCana plc Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-90.2%

Financially safe

Stretched

Debt / equity0.03×

Interest coverage0.0×

Current ratio5.48×

NuCana plc

NCNANASDAQ Global Select·USD·Closed

NuCana plc

NCNANASDAQ·USD·Closed

$1.32

+4.76%

$1.32

+$0.06 (4.76%)

52W Range

1thpctl

Volume

0.46×avg

Mkt Cap

8.02MUSD

P/E

-0.1TTM

Div Yield

–ann

52W Range

1thpctl

Volume

0.46×avg

Market Cap

8.02MUSD

P/E Ratio

-0.1TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings